Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-infected Patients”

1,139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,139 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Not applicableStudy completedNCT00026676
What this trial is testing

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 82
Not applicableLooking for participantsNCT04160455
What this trial is testing

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Who this might be right for
AutophagyGalectinsHIV Infections+1 more
Centre Hospitalier Régional d'Orléans 180
Post-approval studies (Phase 4)UnknownNCT00526448
What this trial is testing

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Who this might be right for
Chronic Hepatitis C
Hospital Carlos III, Madrid 384
Post-approval studies (Phase 4)Study completedNCT01535235
What this trial is testing

ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study

Who this might be right for
HIV
University of California, San Francisco 31
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Post-approval studies (Phase 4)Study completedNCT00466180
What this trial is testing

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University Hospital, Caen 62
Early research (Phase 1)Study completedNCT00001010
What this trial is testing

Zidovudine Plus Acyclovir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Post-approval studies (Phase 4)Study completedNCT01736761
What this trial is testing

A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.

Who this might be right for
HIV
St Stephens Aids Trust 36
Not applicableEnded earlyNCT00001651
What this trial is testing

Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients

Who this might be right for
HIVHealthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Post-approval studies (Phase 4)Study completedNCT00006190
What this trial is testing

Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT00071097
What this trial is testing

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 330
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Not applicableStudy completedNCT00749580
What this trial is testing

A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen

Who this might be right for
Virus DiseasesHIV
University of South Florida 46
Early research (Phase 1)Study completedNCT02388594
What this trial is testing

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Pennsylvania 14
Not applicableEnded earlyNCT00146094
What this trial is testing

Bone Mineral Density (BMD) in HIV Infection

Who this might be right for
OsteopeniaOsteoporosis
University Hospital, Strasbourg, France 44
Large-scale testing (Phase 3)Study completedNCT00670839
What this trial is testing

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Who this might be right for
Hepatitis BHIV Infection
ANRS, Emerging Infectious Diseases 178
Not applicableStudy completedNCT02827227
What this trial is testing

Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)

Who this might be right for
HIV-infected Patients
Hospices Civils de Lyon 99
Testing effectiveness (Phase 2)Study completedNCT01338883
What this trial is testing

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 143
Load More Results